Ouro Fino Saúde Animal Participações S.A (OFSA3) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Ouro Fino Saúde Animal Participações S.A (OFSA3) has a cash flow conversion efficiency ratio of 0.166x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (R$135.27 Million ≈ $26.54 Million USD) by net assets (R$816.49 Million ≈ $160.21 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Ouro Fino Saúde Animal Participações S.A (OFSA3) market capitalisation for the company's overall valuation and market capitalisation.
Ouro Fino Saúde Animal Participações S.A - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how Ouro Fino Saúde Animal Participações S.A's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Ouro Fino Saúde Animal Participações S.A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ouro Fino Saúde Animal Participações S.A ranked by their cash flow conversion efficiency. Explore earnings quality score of Ouro Fino Saúde Animal Participações S.A to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
LINAS AGRO GROUP EO 029
F:YG4
|
0.046x |
|
Hyundai Motor S3 Pref
KO:005389
|
0.011x |
|
Standard Biotools Inc
NASDAQ:LAB
|
-0.019x |
|
What's Cooking Group NV/SA
BR:WHATS
|
0.010x |
|
Langfang Development Co Ltd
SHG:600149
|
-0.013x |
|
Telecomunicações Brasileiras S.A. - TELEBRÁS
SA:TELB3
|
-0.032x |
|
Pengana Private Equity Trust
AU:PE1
|
0.006x |
|
Colonial Coal International Corp
V:CAD
|
-0.023x |
Annual Cash Flow Conversion Efficiency for Ouro Fino Saúde Animal Participações S.A (2011–2025)
The table below shows the annual cash flow conversion efficiency of Ouro Fino Saúde Animal Participações S.A from 2011 to 2025. View Ouro Fino Saúde Animal Participações S.A (OFSA3) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | R$796.86 Million ≈ $156.36 Million |
R$99.91 Million ≈ $19.60 Million |
0.125x | +28.27% |
| 2024-12-31 | R$756.40 Million ≈ $148.42 Million |
R$73.94 Million ≈ $14.51 Million |
0.098x | -64.59% |
| 2023-12-31 | R$689.39 Million ≈ $135.27 Million |
R$190.30 Million ≈ $37.34 Million |
0.276x | +126.76% |
| 2022-12-31 | R$735.95 Million ≈ $144.41 Million |
R$89.59 Million ≈ $17.58 Million |
0.122x | +67.93% |
| 2021-12-31 | R$641.45 Million ≈ $125.86 Million |
R$46.50 Million ≈ $9.12 Million |
0.072x | -63.68% |
| 2020-12-31 | R$560.78 Million ≈ $110.03 Million |
R$111.94 Million ≈ $21.96 Million |
0.200x | +74.32% |
| 2019-12-31 | R$492.45 Million ≈ $96.63 Million |
R$56.39 Million ≈ $11.06 Million |
0.115x | +21.96% |
| 2018-12-31 | R$455.94 Million ≈ $89.46 Million |
R$42.81 Million ≈ $8.40 Million |
0.094x | -61.70% |
| 2017-12-31 | R$405.88 Million ≈ $79.64 Million |
R$99.50 Million ≈ $19.52 Million |
0.245x | +118.41% |
| 2016-12-31 | R$376.33 Million ≈ $73.84 Million |
R$42.24 Million ≈ $8.29 Million |
0.112x | +175.25% |
| 2015-12-31 | R$380.31 Million ≈ $74.62 Million |
R$15.51 Million ≈ $3.04 Million |
0.041x | +1478.41% |
| 2014-12-31 | R$330.16 Million ≈ $64.78 Million |
R$853.00K ≈ $167.37K |
0.003x | -98.38% |
| 2013-12-31 | R$209.42 Million ≈ $41.09 Million |
R$33.45 Million ≈ $6.56 Million |
0.160x | -6.07% |
| 2012-12-31 | R$194.84 Million ≈ $38.23 Million |
R$33.13 Million ≈ $6.50 Million |
0.170x | +114.04% |
| 2011-12-31 | R$177.44 Million ≈ $34.82 Million |
R$14.10 Million ≈ $2.77 Million |
0.079x | -- |
About Ouro Fino Saúde Animal Participações S.A
Ouro Fino Saúde Animal Participações S.A., together with its subsidiaries, engages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals primarily in Brazil. The company operates through three segments: Production Animals; Companion Animals; and International Operations. It manufactures and trades in medicines, including an… Read more